These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

302 related items for PubMed ID: 7646579

  • 1. Pharmacokinetics of the new fluoroquinolone balofloxacin in mice, rats, and dogs.
    Nakagawa T, Ishigai M, Kato M, Hayakawa N, Kinoshita H, Okutomi T, Ohkubo K, Okazaki A.
    Arzneimittelforschung; 1995 Jun; 45(6):719-22. PubMed ID: 7646579
    [Abstract] [Full Text] [Related]

  • 2. Pharmacokinetics of prulifloxacin. 1st communication: absorption, distribution and excretion in rats, dogs and monkeys after a single administration.
    Okuyama Y, Momota K, Morino A.
    Arzneimittelforschung; 1997 Mar; 47(3):276-84. PubMed ID: 9105546
    [Abstract] [Full Text] [Related]

  • 3. Determination of the new fluoroquinolone balofloxacin and its metabolites in biological fluids by high performance liquid chromatography.
    Nakagawa T, Ishigai M, Hiramatsu Y, Kinoshita H, Ishitani Y, Ohkubo K, Okazaki A.
    Arzneimittelforschung; 1995 Jun; 45(6):716-8. PubMed ID: 7646578
    [Abstract] [Full Text] [Related]

  • 4. Pharmacokinetics of prulifloxacin. 2nd communication: pharmacokinetics and effect on hepatic drug-metabolizing enzyme activities after repeated administration and transfer into fetus and milk after a single administration in rats.
    Okuyama Y, Momota K, Morino A.
    Arzneimittelforschung; 1997 Mar; 47(3):285-92. PubMed ID: 9105547
    [Abstract] [Full Text] [Related]

  • 5. Pharmacokinetics of NS-105, a novel cognition enhancer. 1st communication: absorption, metabolism and excretion in rats, dogs and monkeys after single administration of 14C-NS-105.
    Mukai H, Sugimoto T, Ago M, Morino A.
    Arzneimittelforschung; 1999 Nov; 49(11):881-90. PubMed ID: 10604039
    [Abstract] [Full Text] [Related]

  • 6. Metabolic disposition of the new fluoroquinolone antibacterial agent DW116 in rats.
    Park YH, Jung BH, Chung BC, Park J, Mitoma C.
    Drug Metab Dispos; 1997 Sep; 25(9):1101-3. PubMed ID: 9311628
    [Abstract] [Full Text] [Related]

  • 7. Absorption, distribution and excretion of [carbonyl-14C]mosapride citrate after a single oral administration in rats, dogs and monkeys.
    Matsumoto S, Tagawa M, Amejima H, Nakao M, Kagemoto A, Fujii T, Miyazaki H, Sekine Y.
    Arzneimittelforschung; 1993 Oct; 43(10):1084-94. PubMed ID: 8267675
    [Abstract] [Full Text] [Related]

  • 8. The disposition of gemifloxacin, a new fluoroquinolone antibiotic, in rats and dogs.
    Ramji JV, Austin NE, Boyle GW, Chalker MH, Duncan G, Fairless AJ, Hollis FJ, McDonnell DF, Musick TJ, Shardlow PC.
    Drug Metab Dispos; 2001 Apr; 29(4 Pt 1):435-42. PubMed ID: 11259328
    [Abstract] [Full Text] [Related]

  • 9. Pharmacokinetics of the new thyrotropin releasing hormone analogue montirelin hydrate. 1st communication: plasma concentrations, metabolism and excretion after a single intravenous administration to rats, dogs and monkeys.
    Sugimoto T, Hayashi T, Okita A, Morino A.
    Arzneimittelforschung; 1996 Feb; 46(2):106-13. PubMed ID: 8720298
    [Abstract] [Full Text] [Related]

  • 10. Pharmacokinetics of enrofloxacin and its metabolite ciprofloxacin after intravenous and intramuscular administrations in sheep.
    Mengozzi G, Intorre L, Bertini S, Soldani G.
    Am J Vet Res; 1996 Jul; 57(7):1040-3. PubMed ID: 8807018
    [Abstract] [Full Text] [Related]

  • 11. Disposition and metabolism of the new hypocholesterolemic compound S-8921 in rats and dogs.
    Yamaguchi T, Nakajima Y, Mizobuchi M, Inazawa K, Kanazu T, Kadono K, Ohkawa T, Iwatani K.
    Arzneimittelforschung; 1998 Oct; 48(10):995-1006. PubMed ID: 9825117
    [Abstract] [Full Text] [Related]

  • 12. Pharmacokinetics of enrofloxacin after intravenous and intramuscular administration in Angora goats.
    Elmas M, Tras B, Kaya S, Bas AL, Yazar E, Yarsan E.
    Can J Vet Res; 2001 Jan; 65(1):64-7. PubMed ID: 11227198
    [Abstract] [Full Text] [Related]

  • 13. Pharmacokinetics of prulifloxacin. 3rd communication: metabolism in rats, dogs and monkeys.
    Okuyama Y, Morino A.
    Arzneimittelforschung; 1997 Mar; 47(3):293-8. PubMed ID: 9105548
    [Abstract] [Full Text] [Related]

  • 14. Pharmacokinetics and disposition of the oxytocin receptor antagonist L-368,899 in rats and dogs.
    Thompson KL, Vincent SH, Miller RR, Colletti AE, Alvaro RF, Wallace MA, Feeney WP, Chiu SH.
    Drug Metab Dispos; 1997 Oct; 25(10):1113-8. PubMed ID: 9321512
    [Abstract] [Full Text] [Related]

  • 15. Pharmacokinetics of galantamine, a cholinesterase inhibitor, in several animal species.
    Monbaliu J, Verhaeghe T, Willems B, Bode W, Lavrijsen K, Meuldermans W.
    Arzneimittelforschung; 2003 Oct; 53(7):486-95. PubMed ID: 12918214
    [Abstract] [Full Text] [Related]

  • 16. Pharmacokinetics of the gastrokinetic agent mosapride citrate after intravenous and oral administrations in dogs and monkeys.
    Sakashita M, Mizuki Y, Yamaguchi T, Miyazaki H, Sekine Y.
    Arzneimittelforschung; 1993 Aug; 43(8):864-6. PubMed ID: 8216444
    [Abstract] [Full Text] [Related]

  • 17. A new tricyclic fluoroquinolone, rufloxacin (MF-934), with interesting antibacterial and pharmacokinetic characteristics.
    Segre G, Cerretani D, Cerri D, Moltoni L.
    Drugs Exp Clin Res; 1988 Aug; 14(12):747-54. PubMed ID: 3253051
    [Abstract] [Full Text] [Related]

  • 18. Pharmacokinetic evaluation of enrofloxacin in chickens.
    Abd el-Aziz MI, Aziz MA, Soliman FA, Afify NA.
    Br Poult Sci; 1997 May; 38(2):164-8. PubMed ID: 9158891
    [Abstract] [Full Text] [Related]

  • 19. Comparative pharmacokinetics of enrofloxacin in mice, rats, rabbits, sheep, and cows.
    Bregante MA, Saez P, Aramayona JJ, Fraile L, Garcia MA, Solans C.
    Am J Vet Res; 1999 Sep; 60(9):1111-6. PubMed ID: 10490081
    [Abstract] [Full Text] [Related]

  • 20. Pharmacokinetics of (+/-)-4-diethylamino-1,1-dimethylbut-2-yn-1-yl 2-cyclohexyl-2-hydroxy-2-phenylacetate monohydrochloride monohydrate. 1st communication: absorption, distribution and excretion after single administration of 14C-labeled compound to rats and dogs.
    Nakamura A, Sugihara K, Hirota T, Morino A, Ezumi Y, Takaichi M.
    Arzneimittelforschung; 1997 Feb; 47(2):151-9. PubMed ID: 9079234
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.